Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine

Journal of Neural Transmission

Volumn 120, Issue 6, 2013, Pages 987-996

  Matveychuk, Dmitriy ^a   Nunes, Emerson ^a   Ullah, Nasir ^a   Velázquez Martinez, Carlos A ^a   MacKenzie, Erin M ^a   Baker, Glen B ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Phenylethylidenehydrazine; Amino acids; Methylamine; Monoamine oxidase; Phenelzine; Primary amine oxidase

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; AMINO ACID; BETA PHENYLETHYLIDENEHYDRAZINE; DOPAMINE; GLUTAMINE; METHYLAMINE; MONOAMINE OXIDASE INHIBITOR; NEUROTRANSMITTER; NORADRENALIN; PHENELZINE; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; ISOMER; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ANALYSIS;

AMINO ACIDS; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMICAL TECHNIQUES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYDRAZINES; ISOMERISM; MALE; METHYLAMINES; MORPHOLINES; NEUROTRANSMITTER AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84878687109     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-0978-0     Document Type: Article

References (66)

1. Abella A, Garcia-Vicente S, Viguerie N, Ros-Baro A, Camps M, Palacin M, Zorzano A, Marti L (2004) Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 47(3):429-438. doi: 10.1007/s00125-004-1346-2
2. Airas L, Lindsberg PJ, Karjalainen-Lindsberg ML, Mononen I, Kotisaari K, Smith DJ, Jalkanen S (2008) Vascular adhesion protein-1 in human ischaemic stroke. Neuropathol Appl Neurobiol 34(4):394-402. doi: 10.1111/j.1365-2990.2007. 00911.x
3. Baker GB, Coutts RT, Rao TS (1987) Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine. Br J Pharmacol 92(2):243-255
4. Baker GB, Wong JT, Yeung JM, Coutts RT (1991) Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA). J Affect Disord 21(3):207-211
5. Binda C, Jin W, Min L, Hubalek F, Mattevi A, Edmondson DE (2008) Structural and mechanistic studies of arylalkylhydrazine inhibition of human monoamine oxidases A and B. Biochemistry 47(20):5616-5625
6. Boomsma F, Derkx FH, van den Meiracker AH, Man in 't Veld AJ, Schalekamp MA (1995) Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci 88(6):675-679
7. Boomsma F, van Veldhuisen DJ, de Kam PJ, Man in 't Veld AJ, Lie KI, Schalekamp MA (1997) Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res 33(2):387-391
8. Boomsma F, de Kam PJ, Tjeerdsma G, van den Meiracker AH, van Veldhuisen DJ (2000) Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure. Eur Heart J 21(22):1859-1863. doi: 10.1053/euhj.2000.2176
9. Boor PJ, Trent MB, Lyles GA, Tao M, Ansari GA (1992) Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase. Toxicology 73(3):251-258
10. Chen K, Maley J, Yu PH (2006) Potential implications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis. J Neurochem 99(5):1413-1424. doi: 10.1111/j.1471-4159.2006.04181.x
11. Chen K, Kazachkov M, Yu PH (2007) Effect of aldehydes derived from oxidative deamination and oxidative stress on β-amyloid aggregation; pathological implications to Alzheimer's disease. J Neural Transm 114(6):835-839. doi: 10.1007/s00702-007-0697-5
12. Chrapko W, Jurasz P, Radomski MW, Archer SL, Newman SC, Baker G, Lara N, Le Mellédo J-M (2006) Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients. Neuropsychopharmacology 31:1286-1293. doi: 10.1038/sj.npp.1300961
13. del Mar Hernandez M, Esteban M, Szabo P, Boada M, Unzeta M (2005) Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging. Neurosci Lett 384(1-2):183-187. doi: 10.1016/j.neulet.2005.04.074
14. Duffy S, Nguyen PV, Baker GB (2004) Phenylethylidenehydrazine, a novel GABA-transaminase inhibitor, reduces epileptiform activity in rat hippocampal slices. Neuroscience 126:423-432. doi: 10.1016/j.neuroscience.2004.03.007
15. Ferrer I, Lizcano JM, Hernandez M, Unzeta M (2002) Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurosci Lett 321:21-24
16. Garpenstrand H, Ekblom J, Backlund LB, Oreland L, Rosenqvist U (1999) Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy. Diabet Med 16(6):514-521
17. Gerner RH, Hare TA (1981) CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa. Am J Psychiatry 138(8):1098-1101
18. Gold BI, Bowers MB Jr, Roth RH, Sweeney DW (1980) GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry 137(3):362-364
19. Grant SL, Shulman Y, Tibbo P, Hampson DR, Baker GB (2006) Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatogr B Analyt Technol Biomed Life Sci 844(2):278-282. doi: 10.1016/j.jchromb.2006. 07.022
20. Gubisne-Haberle D (2004) Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine. J Pharmacol Exp Ther 310(3):1125-1132. doi: 10.1124/jpet.104.068601
21. Hernandez-Guillamon M, Sole M, Delgado P, Garcia-Bonilla L, Giralt D, Boada C, Penalba A, Garcia S, Flores A, Ribo M, Alvarez-Sabin J, Ortega-Aznar A, Unzeta M, Montaner J (2012) VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke. Cerebrovasc Dis 33(1):55-63. doi: 10.1159/000333370
22. Howard P, Twycross R, Shuster J, Mihalyo M, Rémi J, Wilcock A (2011) Anti-epileptic drugs. J Pain Symptom Manage 42:788-804. doi: 10.1016/j.jpainsymman.2011.10.007
23. Jiang ZJ, Richardson JS, Yu PH (2008) The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathol Appl Neurobiol 34(2):194-204. doi: 10.1111/j.1365-2990.2007.00886.x
24. Karadi I, Meszaros Z, Csanyi A, Szombathy T, Hosszufalusi N, Romics L, Magyar K (2002) Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis. Clin Chim Acta 323(1-2):139-146
25. 123I]iomazenil SPECT. Biol Psychiatry 54(8):792-799
26. Lizcano JM, Fernandez de Arriba A, Tipton KF, Unzeta M (1996) Inhibition of bovine lung semicarbazide-sensitive amine oxidase (SSAO) by some hydrazine derivatives. Biochem Pharmacol 52(2):187-195
27. Lyles GA (1996) Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects. Int J Biochem Cell Biol 28(3):259-274
28. Lyles GA, Chalmers J (1992) The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochem Pharmacol 43(7):1409-1414
29. Lyles GA, McDougall SA (1989) The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazine may be related to the inhibition of semicarbazide-sensitive amine oxidase activities. J Pharm Pharmacol 41(2):97-100
30. MacKenzie EM (2009) Neurochemical and neuroprotective aspects of phenelzine and its active metabolite β-phenylethylidenehydrazine. University of Alberta, Dissertation
31. MacKenzie EM, Fassihi A, Davood A, Chen Q-H, Rauw G, Rauw G, Knaus EE, Baker GB (2008) N-Propynyl analogs of β-phenylethylidenehydrazines: synthesis and evaluation of effects on glycine, GABA, and monoamine oxidase. Bioorg Med Chem 16(17):8254-8263. doi: 10.1016/j.bmc.2008.07.027
32. McManus DJ, Baker GB, Martin IL, Greenshaw AJ, McKenna KF (1992) Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain. Biochem Pharmacol 43(11):2486-2489
33. Meszaros Z, Szombathy T, Raimondi L, Karadi I, Romics L, Magyar K (1999) Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism 48(1):113-117
34. Mitchell SC, Zhang AQ (2001) Methylamine in human urine. Clin Chim Acta 312(1-2):107-114
35. Parent M, Bush D, Rauw G, Master S, Vaccarino F, Baker G (2001) Analysis of amino acids and catecholamines, 5-hydroxytryptamine and their metabolites in brain areas in the rat using in vivo microdialysis. Methods 23(1):11-20. doi: 10.1006/meth.2000.1102
36. Paslawski TM, Sloley BD, Baker GB (1995) Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain. Prog Brain Res 106:181-186
37. Paslawski T, Treit D, Baker GB, George M, Coutts RT (1996) The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology 127(1):19-24
38. Paslawski T, Knaus E, Iqbal N, Coutts R, Baker G (2001) β-Phenylethylidenehydrazine, a novel inhibitor of GABA transaminase. Drug Dev Res 54:35-39
39. Petty F, Sherman AD (1984) Plasma GABA levels in psychiatric illness. J Affect Disord 6(2):131-138
40. Petty F, Kramer GL, Dunnam D, Rush AJ (1990) Plasma GABA in mood disorders. Psychopharmacol Bull 26(2):157-161
41. Petty F, Kramer GL, Gullion CM, Rush AJ (1992) Low plasma gamma-aminobutyric acid levels in male patients with depression. Biol Psychiatry 32(4):354-363
42. Popov N, Matthies H (1969) Some effects of monoamine oxidase inhibitors on the metabolism of gamma-aminobutyric acid in rat brain. J Neurochem 16(3):899-907
43. Precious E, Lyles GA (1988) Properties of a semicarbazide-sensitive amine oxidase in human umbilical artery. J Pharm Pharmacol 40(9):627-633
44. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH (1999) Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56(11):1043-1047
45. Sanacora G, Mason GF, Rothman DL, Krystal JH (2002) Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 159(4):663-665
46. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, Berman RM, Krystal JH (2003) Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 160(3):577-579
47. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF (2004) Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61(7):705-713. doi: 10.1001/archpsyc.61.7.705
48. Schayer RW, Smiley RL, Kaplan EH (1952) The metabolism of epinephrine containing isotopic carbon II. J Biol Chem 198(2):545-551
49. A neurotransmission and cerebral ischemia. J Neurochem 77(2):353-371
50. Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S (1998) Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med 188(1):17-27
51. Song M-S, Baker GB, Dursun SM, Todd KG (2010) The antidepressant phenelzine protects neurons and astrocytes against formaldehyde-induced toxicity. J Neurochem 114:1405-1413. doi: 10.1111/j.1471-4159.2010.06857.x
52. Tanay AI, Parent MB, Wong JTF, Paslawski T, Martin IL, Baker GB (2001) Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain. Cell Mol Neurobiol 21:325-339
53. Tipton KF, Spires IPC (1972) Oxidation of 2-phenylethylhydrazine by monoamine oxidase. Biochem Pharmacol 21:268-270
54. Todd KG, Baker GB (1995) GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline. J Affect Disord 35:125-129
55. Todd KG, Baker GB (2008) Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: a comparison with vigabatrin. J Pharm Pharm Sci 11(2):14s-21s
56. Todd KG, Banigesh AI, Baker GB, Coutts RT, Shuaib A (1999) Phenylethylidenehydrazine, a novel GABA-T inhibitor has neuroprotective actions in transient global ischemia. J Neurochem 73 (Suppl. S202B)
57. Wong JT, Baker GB, Coutts RT, Dewhurst WG (1990) Long-lasting elevation of alanine in brain produced by the antidepressant phenelzine. Brain Res Bull 25(1):179-181
58. Wood P, Khan M, Moskal J, Todd K, Tanay V, Baker G (2006) Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine. Brain Res 1122(1):184-190. doi: 10.1016/j.brainres.2006.09.003
59. Youdim MB, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nature Rev Neurosci 7(4):295-309. doi: nrn188310.1038/nrn1883
60. Yu PH (1990) Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase. J Pharm Pharmacol 42(12):882-884
61. Yu PH, Deng Y (2000) Potential cytotoxic effect of chronic administration of creatine, a nutrition supplement to augment athletic performance. Med Hypotheses 54(5):726-728. doi: 10.1054/mehy.1999.0938
62. Yu PH, Zuo DM (1997) Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia 40(11):1243-1250. doi: 10.1007/s001250050816
63. Yu PH, Lai CT, Zuo DM (1997) Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. Neurochem Res 22(5):615-620
64. Yu PH, Wright S, Fan EH, Lun Z-R, Gubisne-Haberle D (2003) Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim Biophys Acta 1647:193-199. doi: 10.1016/S1570-9639(03)00101-8
65. Zararsiz I, Kus I, Ogeturk M, Akpolat N, Kose E, Meydan S, Sarsilmaz M (2007) Melatonin prevents formaldehyde-induced neurotoxicity in prefrontal cortex of rats: an immunohistochemical and biochemical study. Cell Biochem Funct 25:413-418. doi: 10.1027/cbf.1315
66. Zeisel SH, Wishnok JS, Blusztajn JK (1983) Formation of methylamines from ingested choline and lecithin. J Pharmacol Exp Ther 225(2):320-324